Dr. Reddys Laboratories Ltd

Published Date: 14/06/2011
Category: Drug Delivery & Devices

Research Report Decription

Dr. Reddy's Laboratories Limited - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

• Detailed information on Dr. Reddy's Laboratories Limited required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Dr. Reddy's Laboratories Limited in the form of a SWOT analysis
• An in-depth view of the business model of Dr. Reddy's Laboratories Limited including a breakdown and examination of key business segments
• Intelligence on Dr. Reddy's Laboratories Limited’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Dr. Reddy's Laboratories Limited, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Key Questions Answered:

• Gain understanding of the Dr. Reddy's Laboratories Limited and the factors that influence its strategies 
• Track strategic initiatives of the company and latest corporate news and actions 
• Assess Dr. Reddy's Laboratories Limited as a prospective partners, vendor or supplier 
• Support sales activities by understanding your customers' businesses better

Companies Mentioned:

Dr. Reddy's Laboratories Ltd

Paper Highlights:

Dr. Reddy's Laboratories (Dr. Reddy's) is an integrated global pharmaceutical company. Dr. Reddy's is engaged in the production and distribution of finished dosage forms, active pharmaceutical ingredients and intermediates. It is also involved in the discovery of new chemical entities for subsequent commercialization and out-licensing. The company primarily operates in India, the US, Europe and Russia. It is headquartered in Hyderabad, India, and employed 13,455 people as of March 31, 2010. The company recorded revenues of INR70,277 million ($1,475.8 million*) in the financial year (FY) ended March 2010, an increase of 1.2% over FY2009. The company's operating profit was INR2,008 million ($42.2 million*) in FY2010, as compared to an operating loss of INR2,834 million ($59.5 million*) in FY2009. Its net profit was INR1,068 million ($22.4 million*) in FY2010, as compared to a net loss of INR5,168 million ($108.5 million*) in FY2009. * Calculated using the constant conversion rate of INR1 = $0.0210 during the financial year ended March 31,2010.